The page is the record's research on the issuer — no analyst, no rating, no view.

# HEMOGENYX PHARMACEUTICALS PLC (LSE Main Market: HEMO) — research page

As of 2026-11-06 · uk-cm-kg · record version 1

## Identity and listing

HEMOGENYX PHARMACEUTICALS PLC is listed on the LSE Main Market under ticker HEMO, ISIN GB00BQVXM815 and LEI 2138008L93GYU5GN6179. Its security type is Corporate and its segment is SET3. Its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.

## The disclosure read

The record holds 31 filings on 28 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 10 days, against a median of 4 days for the LSE Main Market and 6.0 days for the sector. Days from the latest filing to the record date are 57, against a median of 3 days for the exchange and 4.0 days for the sector. The latest filing is a ch_capital filing dated 2026-09-10. The exchange median filing count is 29.0 and the sector median is 42 filings.

## Auditor

The auditor of record is PKF Littlejohn LLP. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.

## Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is not set: the issuer is listed, not halted.

## Orderability

For the elective professional client category the outcome is signal ACM-200, determinable. For the eligible counterparty category the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations page. The count is 0.

## Open research

No openly published research notes were found. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. No issuer years are sealed. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.

## Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/HEMO (identity.isin)
- https://find-and-update.company-information.service.gov.uk/company/08401609 (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://www.londonstockexchange.com/stock/HEMO/hemogenyx-pharmaceuticals-plc/company-page (identity.sector)
- https://mcp.uk-cm-kg.ai/events/LSE/HEMO (the disclosure lines)
- https://marketsecurities.fca.org.uk/officiallist (the halt flag)
- https://hemogenyx.com/wp-content/uploads/2023/06/2138008L93GYU5GN6179-2022-12-31-en.html (the auditor)
- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.uk-cm-kg.ai/record/LSE/HEMO (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/uk/LSE/HEMO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp